REPEAT BLOOD-BRAIN BARRIER DISRUPTION IN PATIENTS WITH RECURRENT PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

被引：0
|
作者：
Mcgregor, John [1 ]
Bourekas, Eric [1 ]
Bell, Susan [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
来源：
NEURO-ONCOLOGY | 2008年 / 10卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：912 / 912
页数：1
相关论文
共 50 条
  • [1] Primary Central Nervous System Lymphoma and the Blood-Brain Barrier
    Doolittle, Nancy D.
    Fu, Rochelle
    Ambady, Prakash
    Neuwelt, Edward A.
    [J]. BLOOD, 2016, 128 (22)
  • [2] Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma
    Galor, Anat
    Ference, Sandra J.
    Singh, Arun D.
    Lee, Michael S.
    Stevens, Glen H. J.
    Perez, Victor L.
    Peereboom, David M.
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 144 (01) : 45 - 49
  • [3] Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma
    Goldstein, Debra A.
    Tessler, Howard H.
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 144 (06) : 976 - 976
  • [4] DEGREE OF BLOOD-BRAIN BARRIER DISRUPTION AND CUMULATIVE TOTAL DOSE INTENSITY IN THE TREATMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
    Kraemer, D. F.
    Angelov, L.
    Doolittle, N. D.
    Siegal, T.
    Peereboom, D.
    Jahnke, K.
    Shalom, E.
    Barnett, G.
    McGregor, J.
    Neuwelt, E. A.
    [J]. NEURO-ONCOLOGY, 2008, 10 (06) : 1070 - 1070
  • [5] Blood-Brain Barrier Disruption: A Common Driver of Central Nervous System Diseases
    Segura-Collar, Berta
    Mata-Martinez, Pablo
    Hernandez-Lain, Aurelio
    Sanchez-Gomez, Pilar
    Gargini, Ricardo
    [J]. NEUROSCIENTIST, 2022, 28 (03): : 222 - 237
  • [6] Osmotic blood-brain barrier disruption with mannitol followed by methotrexate, rituximab, and carboplatin in treating patients with newly diagnosed primary central nervous system lymphoma
    Ambady, Prakash
    Doolittle, Nancy Diane
    Neuwelt, Edward A.
    Fu, Rongwei
    Teglassy, Gerda
    Vo, Anh Huan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Matrix metalloproteinases cause blood-brain barrier disruption in central nervous system tuberculosis
    Brilha, Sara
    Ong, Catherine W. M.
    Friedland, Jon S.
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2014, 275 (1-2) : 27 - 27
  • [8] Blood-Brain Barrier Disruption (BBBD)-Based Immunochemotherapy for Primary Central Nervous System Lymphoma (PCNSL), Early Results of a Phase II Study
    Kuitunen, Hanne K.
    Ronka, Aino L. K.
    Sonkajarvi, Eila M.
    Isokangas, Juha-Matti
    Pyorala, Marja
    Palosaari, Kari A. A.
    Jokimaki, Anna S.
    Partanen, Anu E.
    Littow, Harri J.
    Vakkala, Merja A.
    Jantunen, Esa J.
    Huttunen, Mirja E.
    Marin, Katja J.
    Aromaa-Hayha, Annikki M. K.
    Auvinen, Paivi K.
    Selander, Tuomas
    Puhakka, Inka K.
    Kuittinen, Outi M.
    [J]. CANCERS, 2023, 15 (04)
  • [9] Role of the Blood-Brain Barrier in the Nutrition of the Central Nervous System
    Campos-Bedolla, Patricia
    Walter, Fruzsina R.
    Veszelka, Szilvia
    Deli, Maria A.
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2014, 45 (08) : 610 - 638
  • [10] Immunologic privilege in the central nervous system and the blood-brain barrier
    Muldoon, Leslie L.
    Alvarez, Jorge I.
    Begley, David J.
    Boado, Ruben J.
    del Zoppo, Gregory J.
    Doolittle, Nancy D.
    Engelhardt, Britta
    Hallenbeck, John M.
    Lonser, Russell R.
    Ohlfest, John R.
    Prat, Alexandre
    Scarpa, Maurizio
    Smeyne, Richard J.
    Drewes, Lester R.
    Neuwelt, Edward A.
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2013, 33 (01): : 13 - 21
12345